Halozyme Therapeutics (HALO) Acquisitions (2026)
Halozyme Therapeutics (HALO) reported Acquisitions of $710000.0 for Q1 2026.
Halozyme Therapeutics (HALO) Acquisitions (2026) Analysis & Trends
Halozyme Therapeutics (HALO) has 1 years of Acquisitions data on file, last reported at $710000.0 in Q1 2026.
- Acquisitions for Q1 2026 came in at $710000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $710000.0 (changed N/A YoY), and the FY2025 annual result was $726.0 million, changed N/A from the prior year.
- Acquisitions held at $710000.0 in Q1 2026 per HALO's latest filing.
- Over five years, Acquisitions peaked at $710000.0 in Q1 2026 and troughed at $710000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Halozyme Therapeutics | 8.24 Bn | 7.92 Bn | 297.47 Mn | 710,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 710,000.00 |